Tharimmune (THAR) Stock: Biotech Company Secures $540M for Canton Coin Treasury Strategy

TLDR Tharimmune secured $540 million in private funding to build a Canton Coin treasury strategy and become a Super Validator on the Canton Network. DRW and Liberty City Ventures led the round, with ARK Invest, Kraken, Polychain Capital, and other institutional investors participating at $3.075 per share. The company will purchase Canton Coin tokens and [...]

The post Tharimmune (THAR) Stock: Biotech Company Secures $540M for Canton Coin Treasury Strategy appeared first on Blockonomi.